QC
EVLV icon

Quantessence Capital’s Evolv Technologies EVLV Stock Holding History

Quantessence Capital’s Portfolio EVLV Stock Details EVLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,871
Closed -$67.8K – 224
2025
Q2 		$67.8K Buy
+10,871
New +$50.3K 0.02% 179

Other funds holding EVLV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
KCM
Key Colony Management Little Rock, Arkansas $73.7M AUM 49.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $9.44B AUM 18.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Quantessence Capital's EVLV Position: Q3 2025 in Review

Quantessence Capital sold out of Evolv Technologies (EVLV) in Q3 2025, closing a stake of 10,871 shares — an estimated $67.8K sold.

Quantessence Capital first reported a position in EVLV in Q2 2025 and held it in 1 quarter. The position peaked at $67.8K in Q2 2025. 244 funds tracked by Wall St. Rank hold EVLV as of Q3 2025.

  • Quantessence Capital reported no remaining Evolv Technologies position as of Q3 2025 after selling out during the quarter.
  • Quantessence Capital sold 10,871 Evolv Technologies shares in Q3 2025, an estimated $67.8K.
  • Quantessence Capital first reported a position in Evolv Technologies in Q2 2025 and held it in 1 quarter.
  • Quantessence Capital's Evolv Technologies position peaked at $67.8K in Q2 2025.
  • 244 funds tracked by Wall St. Rank held Evolv Technologies as of Q3 2025.

Based on Quantessence Capital's 13F filing for Q3 2025, filed 14 Nov 2025.